Hakutulokset - Ritsuro Suzuki
- Näytetään 1 - 20 yhteensä 66 tuloksesta
- Siirry seuraavalle sivulle
-
1
-
2
Advances in the treatment of extranodal NK/T-cell lymphoma, nasal type Tekijä Motoko Yamaguchi, Ritsuro Suzuki, Masahiko Oguchi
Julkaistu 2018Revisão -
3
Extranodal NK/T‐cell lymphoma: diagnosis and treatment cues Tekijä Ritsuro Suzuki, Kengo Takeuchi, Koichi Ohshima, Shigeo Nakamura
Julkaistu 2008Revisão -
4
-
5
-
6
-
7
-
8
Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia Tekijä Yasuhiro Kondoh, Hiroyuki Taniguchi, Takashi Yokoi, Osamu Nishiyama, T Ohishi, Terufumi Kato, Kyoko Suzuki, Ritsuro Suzuki
Julkaistu 2005Artigo -
9
-
10
Aggressive natural killer cell leukemia: Therapeutic potential of <scp>l</scp>‐asparaginase and allogeneic hematopoietic stem cell transplantation Tekijä Fumihiro Ishida, Young Hyeh Ko, Won Seog Kim, Junji Suzumiya, Yasushi Isobe, Kazuo Oshimi, Shigeo Nakamura, Ritsuro Suzuki
Julkaistu 2012Artigo -
11
Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM Tekijä Hiroyuki Tagawa, Sivasundaram Karnan, Ritsuro Suzuki, Keitaro Matsuo, Xiaohua Zhang, Akinobu Ota, Yasuo Morishima, Shigeo Nakamura, Masao Seto
Julkaistu 2004Artigo -
12
API2-MALT1 Chimeric Transcripts Involved in Mucosa-Associated Lymphoid Tissue Type Lymphoma Predict Heterogeneous Products Tekijä Mutsuhito Motegi, Masakatsu Yonezumi, Hiroko Suzuki, Ritsuro Suzuki, Yoshitaka Hosokawa, Shigetoshi Hosaka, Yoshihisa Kodera, Yasuo Morishima, Shigeo Nakamura, Masao Seto
Julkaistu 2000Artigo -
13
A novel gene, MALT1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue Tekijä Tomoaki Akagi, Mutsuhito Motegi, Akiko Tamura, Ritsuro Suzuki, Yoshitaka Hosokawa, Hiroko Suzuki, Hiroyoshi Ota, Shigeo Nakamura, Yasuo Morishima, Masafumi Taniwaki, Masao Seto
Julkaistu 1999Artigo -
14
Epidemiological analysis of multicentric and unicentric Castleman disease and TAFRO syndrome in Japan Tekijä Yasufumi Masaki, Hiroshi Kawabata, Shino Fujimoto, Mitsuhiro Kawano, Noriko Iwaki, Takeharu Kotani, Akikatsu Nakashima, Nozomu Kurose, Kazue Takai, Ritsuro Suzuki, Sadao Aoki
Julkaistu 2019Artigo -
15
Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5 Tekijä Takuhei Murase, Motoko Yamaguchi, Ritsuro Suzuki, Masataka Okamoto, Yumiko Sato, Jun‐ichi Tamaru, Masaru Kojima, Ikuo Miura, Naoyoshi Mori, Tadashi Yoshino, Shigeo Nakamura
Julkaistu 2006Artigo -
16
Impact of pretransplant body mass index on the clinical outcome after allogeneic hematopoietic SCT Tekijä Shigeo Fuji, Kuniko Takano, Takehiko Mori, Tetsuya Eto, Shuichi Taniguchi, Kazuteru Ohashi, Hisashi Sakamaki, Y Morishima, Ken Kato, Koichi Miyamura, Ritsuro Suzuki, Takahiro Fukuda
Julkaistu 2014Artigo -
17
Phase I study of dexamethasone, methotrexate, ifosfamide, <scp>l</scp>‐asparaginase, and etoposide (SMILE) chemotherapy for advanced‐stage, relapsed or refractory extranodal natura... Tekijä Motoko Yamaguchi, Ritsuro Suzuki, Yok‐Lam Kwong, Won Seog Kim, Yuichi Hasegawa, Koji Izutsu, Junji Suzumiya, Takayuki Okamura, Shigeo Nakamura, Keisei Kawa, Kazuo Oshimi
Julkaistu 2008Artigo -
18
CD5 expression is potentially predictive of poor outcome among biomarkers in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy Tekijä Daisuke Ennishi, Kengo Takeuchi, Masaru Yokoyama, Hiroaki Asai, Yuko Mishima, Y. Terui, Shunji Takahashi, Hirotake Komatsu, Kazuma Ikeda, Motoko Yamaguchi, Ritsuro Suzuki, Mitsune Tanimoto, Kiyohiko Hatake
Julkaistu 2008Artigo -
19
CD7+ and CD56+ Myeloid/Natural Killer Cell Precursor Acute Leukemia: A Distinct Hematolymphoid Disease Entity Tekijä Ritsuro Suzuki, Kazuhito Yamamoto, Masao Seto, Yoshitoyo Kagami, Michinori Ogura, Yasushi Yatabe, Taizan Suchi, Yoshihisa Kodera, Yasuo Morishima, Takashi Takahashi, Hidehiko Saito, Ryuzo Ueda, Shigeo Nakamura
Julkaistu 1997Artigo -
20
Hematopoietic stem cell transplantation for core binding factor acute myeloid leukemia: t(8;21) and inv(16) represent different clinical outcomes Tekijä Yachiyo Kuwatsuka, Koichi Miyamura, Ritsuro Suzuki, Masaharu Kasai, Atsuo Maruta, Hiroyasu Ogawa, Ryuji Tanosaki, Satoshi Takahashi, Kyuhei Koda, Kazuhiro Yago, Yoshiko Atsuta, Takashi Yoshida, Hisashi Sakamaki, Yoshihisa Kodera
Julkaistu 2009Artigo
Työkalut:
Liittyvät aiheet
Medicine
Internal medicine
Lymphoma
Immunology
Oncology
Biology
Gastroenterology
Transplantation
Genetics
Hematopoietic stem cell transplantation
Chemotherapy
Surgery
Leukemia
Pathology
Bone marrow
Gene
Stem cell
Disease
Confidence interval
Diffuse large B-cell lymphoma
Cancer research
Hazard ratio
Retrospective cohort study
Haematopoiesis
T-cell lymphoma
Rituximab
Virus
Acute leukemia
Antibody
Antigen